Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,823 | -3,143 | -1,745 | -5,908 | -4,469 |
| Depreciation Amortization | 430 | 285 | 143 | 619 | 474 |
| Accounts receivable | 82 | 38 | -96 | 89 | 155 |
| Other Working Capital | 13 | -330 | -381 | 233 | -47 |
| Other Operating Activity | 52 | 119 | 237 | 8 | 30 |
| Operating Cash Flow | $-4,245 | $-3,030 | $-1,842 | $-4,960 | $-3,856 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | -994 |
| PPE Investments | -34 | N/A | N/A | 20 | -1 |
| Purchase Sale Intangibles | -190 | N/A | N/A | -409 | N/A |
| Other Investing Activity | -190 | -124 | -44 | -409 | -242 |
| Investing Cash Flow | $-224 | $-124 | $-44 | $-389 | $-1,238 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,000 | 1,000 | 1,000 | N/A | N/A |
| Debt Repayment | -1,021 | -1,021 | -1,020 | 4 | -22 |
| Common Stock Issued | 757 | 185 | 15 | 4,121 | 4,640 |
| Other Financing Activity | 7,178 | 0 | 0 | 469 | 0 |
| Financing Cash Flow | $7,913 | $164 | $-6 | $4,594 | $4,618 |
| Beginning Cash Position | 875 | 875 | 875 | 1,813 | 1,813 |
| End Cash Position | 7,359 | 924 | 2,023 | 875 | 1,365 |
| Net Cash Flow | $6,483 | $49 | $1,147 | $-938 | $-448 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,245 | -3,030 | -1,842 | -4,960 | -3,856 |
| Capital Expenditure | -34 | N/A | N/A | 20 | N/A |
| Free Cash Flow | -4,279 | -3,030 | -1,842 | -4,940 | -3,856 |